Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Ismail Jatoi, M.D., PhD, FACS, UT Health San Antonio

Contact

210-450-5990

Departments & Divisions

Institutes & Centers

Ismail Jatoi, M.D., Ph.D., FACS

Professor of Surgery, UT Health San Antonio

Dale H. Dorn Chair in Surgery

Dr. Ismail Jatoi is Professor in the Division of Surgical Oncology and Endocrine Surgery at UT Health San Antonio. He obtained his undergraduate bachelor’s degree from Washington University in St. Louis and his MD and PhD degrees from St. Louis University. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital in London, England. Dr. Jatoi served in the U.S. military for many years, and was a Professor of Surgery at the Uniformed Services University in Bethesda, Maryland. He retired from the U.S. Army with the rank of Colonel. Dr. Jatoi has had a longstanding interest in the treatment of breast cancer, the management of women at increased risk for breast cancer, and cancer epidemiology.

 

  • Professional Background

    Education

    • 1985 - M.D. - Medical Doctor - St. Louis University, St. Louis, MO
    • 1981 - PhD - Pharmacology - St. Louis University, St. Louis, MO
    • 1977 - A.B. - Biology and Chemistry - Washington University, St. Louis, MO

    Training

    • 1994 - Fellolwship - Surgical Oncology (Senior Registrar) - Royal Marsden Hospital, London, England
    • 1990 - Chief Resident - General Surgery - Madigan Army Medical Center, Tacoma, WA
    • 1989 - Residency - General Surgery - University of California, San Francisco, CA
    • 1987 - Residency - General Surgery - University of Chicago Hospitals and Clinics, Chicago, IL
    • 1986 - Internship - General Surgery - University of Chicago

    Highlights

    1. Legion of Merit
    2. Bronze Star Medal
    3. Meritorious Service Medal
    4. Army Commendation Medal (3 Awards)
    5. Army Achievement Medal (2 Awards)
    6. National Defense Service Medal (2 Awards)
    7. Armed Forces Expeditionary Medal
    8. Iraq Campaign Medal
    9. Global War on Terrorism Expeditionary Medal
    10. Global War on Terrorism Service Medal
    11. Korean Defense Service Medal
    12. Armed Forces Reserve Medal
    13. Army Service Ribbon
    14. Overseas Service Ribbon (4 Awards)
    15. North Atlantic Treaty Organization (NATO) Medal

    Appointments

    • 1/2010 - Professor and Chief for Division of Surgical Oncology - University of Texas Health Science Center at San Antonio, Surgery, San Antonio
    • 1/2010 - Adjunct Professor - Uniformed Services University, Surgery, Bethesda

  • Research & Grants

    Breast Cancer, Cancer Prevention, Clinical Trials, Genetics of Cancer, Screening

    Population Science and Prevention Program 

    Grants

    Federal

    Funding Agency NIH/NCI Title Aging mammary stem cells and breast cancer prevention Status Active Period 9/2015 - 6/2020 Role Co-Investigator Grant Detail Our long-term goal is to determine how aging-related breast cancer can be specifically targeted and prevented. Funding Agency NIH/NCI Title miRNAs: Safe and effective therapeutic adjuvants for treating drug resistant TNBCs Status Active Period 2/2015 - 1/2020 Role Co-Investigator Grant Detail This work will determine if candidate miRNA sensitizes cellular response to taxol by targeting microtubule-associated proteins, and if candidate miRNA affects taxol response by targeting DNA damage surveillance pathway. In addition, we will study the therapeutic potential of candidate miRNAs in improving the efficacy of taxol for treating therapy resistant TNBC using a tumor xenograft mouse model and syngeneic mouse model with intact immune system. Funding Agency NIH/NCI Title NRG Oncology Purchased Service Agreement Status Active Period 3/2014 - 2/2019 Role Principal Investigator Grant Detail The major goal for this project is to provide services as an NRG Oncology Member Institution for the NCI's National Clinical Trials Network (NCTN). Dr. Jatoi oversees patient randomization and services related to studies funded under the NCTN award.

  • Publications

      Publications:

      Benson JR, Dumitru D, Jatoi I. Highlights of the San Antonio Breast Cancer Symposium 2019 Part 2: the challenges of tumor heterogeneity. Future Oncol. 2020 Jul;16(21):1503-1509.

      Benson JR, Dumitru D, Jatoi I. Highlights of the San Antonio Breast Cancer Symposium 2019 Part 1: the challenges of tumor heterogeneity. Future Oncol. 2020 Jul;16(21):1497-1502.

      Owusu-Brackett N, Menon PD, Nazarullah A, Jatoi I, Elmi M.  Bilateral Paget’s Disease of the breast in a patient with CHEK2 mutation.  European Journal of Breast Health 2020; April 1; 16(2): 152-154.

      Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, Dragun A, Gelpi JB, Hofstatter EW, Isaacs CJ, Jatoi I, Kennedy E, Litton JK, Mayr NA, Qamar RD, Trombetta MG, Harvey BE, Somerfield MR, Owusu-Brackett N, Menon PD, Nazurullah A, Jatoi I, Elomi M.  BZakalik D.  Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.  Journal of Clinical Oncology 2020 Jun 20;38(18):2080-2106. 

      Jatoi I.  Breast cancer screening: a paradigm change is needed—the PB Desai Oration.  Indian Journal of Surgical Oncology 2020; March 11(1): 19-22.

      Wadhwani N, Jatoi I.  Overuse of Neo-adjuvant chemotherapy for primary breast cancer.  Indian Journal of Surgical Oncology 2020; March 11(1); 12-14.

      Jatoi I.  Residual confounding threatens the validity of observational studies on breast cancer local therapy.  Cancer 2020 January 30 (Epub ahead of print)

      Jatoi I, Benson JR.  Epidemiologic signatures in cancer (Letter).  N Engl J Med 2020; Jan 2; 382 (1); 95-96.

      Chen G, Ding X, Presssley K, Bouamar H, Wang B, Zheng G, Broome L, Nazarullah A, Brenner AJ, Kaklamani V, Jatoi I, Sun L.  Everolimus inhibits the progression of ductal carcinoma in situ to invasive breast cancer via donwnregulation of MMP9 expression.  Clin Cancer Res. 2019 Dec 23. pii: clincanres.2478.2019. doi: 10.1158/1078-0432.CCR-19-2478. [Epub ahead of print]PMID:31871301

      Jatoi I, Gail MH.  The need for combined assessment of multiple outcomes in noninferiority trials in oncology. JAMA Oncology 2019; Dec 12 (Epub ahead of print).

      Benson JR, Jatoi I.  Extended endocrine therapy in early breast cancer: how long and who for?  Future Oncology 2020; Jan; 16(1): 4327-4336

      Eaglehouse YL, Georg MW, Jatoi I, Shriver CD, Zhu K.  Factors related to re-excision procedures following primary breast-conserving surgery for women with breast cancer in the U.S. military health system.  Journal of Surgical Oncology 2019 Nov 29 (Epub ahead of print)

      Blaes AH, Jewett PI, McKay K, Riley D, Jatoi I, Trentham-Dietz A, Chrischilles E, Klemp JP.  Factors associated with genetic testing in a cohort of breast cancer survivors.  Breast Journal 2019; July 3 2019 (Epub ahead of print)

      Zhang X, Wang Y, Chiang HC, Hsieh YP, Lu C, Park BH, Jatoi I, Jin VX, Hu Y, Li R.  BRCA 1 mutations attenuate super-enhancer function and chromatin looping in haploiinsufficient human breast epithelial cells.  Breast Cancer Research 2019; 21(1): 51.

      Chiang HC, Zhang X, Li J, Zhao X, Chen J, Wang HT, Jatoi I, Brenner A, Hu Y, Li R.  BRCA 1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.  Nucleic Acids Research 2019; 47(10): 5086-5099.

      Benson J.R, Jatoi I, Toi M.  Surgical management of multiple ipsilateral breast cancers.  Future Oncology 2019; 15(11): 1185-1191.

      Jatoi I, Anderson WF, Miller AB, Brawley O.  History of cancer screening.  Current Problems in Surgery 2019; 56(4): 129-164.

      Jatoi I, Sah S.  Clinical practice guidelines and the overuse of healthcare services: need for reform.  Canadian Medical Association Journal 2019; 191(11): E207-E298.

      Jatoi I, Benson J.R., Toi M.  Breast cancer over-diagnosis: an adverse consequence of mammography screening—highlights of the 2018 Kyoto Breast Cancer Consensus Conference.  Future Oncology 2019; March 18, 2019 [Epub ahead of print].

      Gerall CD, Jatoi I.  Gestational gigantomastia.  Surgery 2019; 165(2): 485

      Jatoi, I. Risk-reducing options for women with a hereditary breast cancer predisposition.  European Journal of Breast Health 2018; 14(4): 189-193

      Winters ZE, Horsnell J, Elvers KT, Maxwell AJ, Jones LJ, Shaaban AM, Schmid P, Williams NR, Beswick A, Greenwood R, Ingram JC, Saunders C, Vaidya JS, Esserman L, Jatoi I, Brunt AM.  Systemic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.  BJS Open 2018; 22: 2(4): 162-174

      Benson JR, Jatoi I.  Tailoring breast cancer therapies to reduce mortality and improve quality of life; San Antonio Breast Cancer Symposium 2017 (part 2).  Future Oncology 2018; 14(19): 1893-1896.

      Benson JR, Jatoi I.  Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).  Future Oncology 2018; 14(19): 1889-1992.

      Jatoi I, Benson JR, Kunkler I.  Hypothesis: can the abscopal effect explain the impact of breast cancer adjuvant radiotherapy on breast cancer mortality?  NPJ Breast Cancer 2018; Apr 3;4:8. doi: 10.1038/s41523-018-0061-y. eCollection 2018. Review.

      Jatoi I, Benson JR.  Surgical Management of the Axilla in Early Breast Cancer. Current Problems in Surgery 2018; 55(2): 47-65.

      Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, Zhu K.  Diabetes and overall survival among breast cancer patients in the U.S. military health system.  Cancer Epidemiol Biomarkers Prevention. 2018; 27(1): 50-57.

      Benson JR, Jatoi I.  Highlights of the San Antonio Breast Cancer Symposium 2016 (part 2).  Future Oncology 2017 Jul; 13(16):1365-1369.

      Benson JR, Jatoi I.  Highlights of the San Antonio Breast Cancer Symposium 2016.   Future Oncology 2017; 13(15): 1291-1295.

      Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zharo X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R.   Attenuation of RNA polymerase II pausing mitigates BRCA 1-associated R-loop accumulation and tumorigenesis.  Nature Communications 2017; 8: 15908.

      Jatoi I. Reconsidering axillary surgery for early breast cancer.  Indian Journal of Medical Research 2017; 145 (2): 155-157.

      Jatoi, I, Anderson WF.  Breast cancer tumor size and screening effectiveness.  N Engl J Med 2017; 376 (1): 93.

      Benson JR, Jatoi I, Toi M.  Treatment of low-risk ductal carcinoma in situ: is nothing better than something?  Lancet Oncology 2016; 17(10): e442-e451.

      Jatoi I, Benson JR, Toi M.  De-escalation of axillary surgery in early breast cancer.  Lancet Oncology 2016; 17(10): e430-e441.

      Jatoi I, Benson JR.  Management of women with a hereditary predisposition for breast cancer.  Future Oncology 2016; 12(19): 2277-2288.

      Jatoi I.  Bilateral mastectomy for unilateral breast cancer: a perplexing trend.  Indian Journal of Surgical Oncology 2015; 6(4): 387-389.

      Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL.  Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications.  Journal of Clinical Oncology 2016; 34(18): 2093-2097.

      Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.  Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.  Cancer Epidemiol 2016; 42: 24-31.

      Benson JR, Jatoi I.  Highlights of the San Antonio Breast Cancer Symposium 2015: part 2. Future Oncology 2016; 12(7): 897-200.

      Benson JR, Jatoi I.  Highlights of the San Antonio Breast Cancer Symposium 2015; part 1. Future Oncology 2016; 12(7): 893-896.

      Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L, Jatoi I, Brunt AM; MIAMI Trial Management Group.  Breast 2016; 26: 149-150.

      Jatoi I, Bandos H, Jeong JH, Anderson WF, Romond E, Mamounas E, Wolmark N.  Time-varying effects of breast cancer adjuvant systemic therapy.  Journal of the National Cancer Institute 2015; October 30; 108(1).  Print 2016 Jan

      Jatoi I, Miller AB.  Mammography Screening in Elderly Women: Primum Non Nocere.  JAMA Surgery 2015 Dec; 150(12): 1107-8.

      Jatoi I. Breast Cancer Screening: Past, Present, and Future.  Future Oncology 2015, Sept 4 (Epub ahead of print). 

      Jatoi I. Breast Cancer Screening—Viewpoint of the IARC Working Group (Letter).  N Engl J Med 2015; Oct 8; 373 (15): 1478-9.

      Hsu P-Y, Hsu H-K, Hsiao T-H, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH-M.  Spatiotemporal control of estrogen-responsive transcription in ER-positive breast cancer cells.  Oncogene 2016 May 5;35(18):2379-89.

      Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Jr WL, Miller A, Prorok PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P.  Changes in and impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.  Rev Recent Clin Trials 2015; 10(3): 206-11.

      Chiang HC, Elledge R, Larson P, Jatoi I, Li R, Hu Y.  Effects of radiation therapy on breast epithelial cells in BRCA1/2 Mutation Carriers.  Breast Cancer (Auckl) 2015 Jun 2; 9:25-9.

      Kidd AD, Colbert AM, Jatoi I.  Mammography: review of the controversy, health disparities, and impact on young African American women. Clin J Oncol Nurs 2015 Jun; 19(3): E52-8.

      Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, et al.  Personalization of loco-regional care for primary breast cancer patients (part 2).  2014 Kyoto Breast Cancer Consensus Conference.  Future Oncol 2015; 11(9): 1301-5.

      Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I,  Sasano H, et al.  Personalization of loco-regional cre for primary breast cancer patients (part 1).  2014 Kyoto Breast Cancer Consensus Conference.  Future Oncol 2015; 11(9): 1297-300.

      Jatoi I.  Postmastectomy radiotherapy in patients with breast cancer.  Lancet 2014; Nov 22; 383(9957): 1844-5.

      Jatoi I, Parsons HM.  Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.  Breast Cancer Research and Treatment 2014 Nov; 148(2): 389-96.

      Halsted CP, Benson JR, Jatoi I.  A historical account of breast cancer surgery: beware of local recurrence but be not radical.  Future Oncology 2014; 10(9): 1649-57.

      McGinity AC, Lautner MA, Jatoi I.  Management of the clinically node-negative axilla in primary and locally recurrent breast cancer.  Surg Oncol Clin N Am 2014; Jul 23(3): 463-471.

      Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K.   Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.  Cancer Causes Control. 2014 Aug;25(8):959-68.

      Benson JR, Jatoi I.  Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients.  Future Oncol 2014; 10(4): 577-586.

      Jatoi I, Benson JR.  Novel approaches to the diagnosis and treatment of breast cancer.  Future Oncol 2014; 10(4): 515-518.

      Jatoi I.  The effect of local therapy on breast cancer mortality: is there an age-interaction?  Indian Journal of Surgical Oncology 2014; 5(1): 5-9.

      Jatoi I.  Breast cancer screening recommendations.  JAMA 2013; 310(19):    2101-2.

      Enewold L, McGlynn KA, Zahm SH, Jatoi I, Anderson WF, Gill AA, Shriver CD, Zhu K.   Surveillance mammography among female Department of Defense beneficiaries: A study by race and ethnicity.  Cancer 2013; 119(19): 3531-8.

      Zhou J, Enewold L, Zahm SH, Jatoi I, Shriver C, Anderson WF, Jeffery DD, Andaya A, Potter JF, McGlynn KA, Zhu K.  Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system.  Am J Surgery 2013 Sep; 206 (3): 393-9.

      Holloway TL, Jatoi I.  Tumorous PASH presenting as rapid unilateral breast enlargement.  Mayo Clin Proc 2013; 88(7): e75.

      Jatoi I.  The benefits and harms of breast cancer screening.  Lancet 2013 Marc 9; 381(9869): 803.

      Jatoi I, Benson JR.  The case against routine preoperative breast MRI.  Future Oncol 2013; 9(3): 347-53.

      Jatoi I.  Reducing reoperation rates after breast-conserving surgery.  Lancet Oncology 2013; 14(1): 5-6.

      Jatoi I.  Surgical margins in lumpectomy for breast cancer.  N Engl J Med 2012; 367(13): 1269-1270.

      Benson JR, Jatoi I.  The global breast cancer burden.  Future Oncology 2012; 8(6): 697-702.

      Kumar A, Puri R, Gadgil PV, Jatoi I.  Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla.  World Journal of Surgery 2012; 36(7): 1453-1459.

      Andaya AA, Enewold L, Horner M, Jatoi I, Shriver CD, Zhu K.  Socioeconomic Disparities and Breast Cancer Hormone Receptor Status.  Cancer Causes and Control 2012; 23(6): 951-958.

      Jatoi  I, Options in Breast Cancer Local Therapy: Who Gets What?  World Journal of Surgery 2012; 36(7): 1498-1502.

      Gabriel EM, Jatoi I.  Breast Cancer Chemoprevention.  Expert Review of Anticancer Therapy 2012; 12(2): 223-228.

      Oppeltz RF, Jatoi I.  Tobacco and the escalating global cancer burden.  J Oncol 2011; 2011: 408104. Epub 2011 Aug 18

      Jatoi  I.  The impact of advances in treatment on the efficacy of mammography screening.  Prev Med  2011; 53(3): 103-4.  Epub 2011 Jun 23.

      Buys SS, Partridge E, Black A, et al.  PLCO Project Team.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Trial.  JAMA 2011; 305(22): 2295-303.

      Jatoi I.  Axillary vs sentinel node dissection for invasive breast cancer (letter).  JAMA 2011; 305(22): 2288.; author reply 2290-1.

      Jatoi  I, Anderson WF, Jeong JH, Redmond CK.  Breast Cancer Adjuvant Therapy:  Time to Consider its Time-Dependent Effects.  Journal of Clinical Oncology 2011; 29(17): 2301-2304.  Epub 2011 May 9.

      Jatoi I, Anderson WF.  Lessons from the Mammography Wars (letter).  N Engl J Med 2010; 363(26):2569-2570.

      Jatoi I, Anderson WF.  Qualitative Age-Interactions in Breast Cancer Studies: a Mini-review.  Future Oncology 2010; 6(11): 1781-1788.

      Jatoi  I, Benson JR, Liau S, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti M.  The Role of Surgery in Cancer Prevention.  Current Problems in Surgery 2010; 47(10): 737-832.

      Rosenberg PS, Menashe I, Jatoi I, Anderson WF.  Re: Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.  Journal of the National Cancer Institute 2010; 102(4): 277.

      Anderson WF, Jatoi I, Tse J, Rosenberg PS.  Male breast cancer: a population-based comparison with female breast cancer.  Journal of Clinical Oncology 2010; 28(2): 232-239.

      Anderson WF, Jatoi I, Sherman ME.  Qualitative age interactions in breast   cancer studies: “mind the gap”.  Journal of Clinical Oncology 2009;  7(32): 5308-5311.

      Menashe I, Anderson WF, Jatoi I, Rosenberg PS.  Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.  J Natl Cancer Inst 2009; 101(14): 993-1000. 

      Anderson WF, Jatoi I.  Age-related crossover in breast cancer incidence rates between black and white women: implications for removing racial disparities in breast cancer care.  Breast Diseases: A Year Book Quarterly 2009; 20(2): 132-134.

      Zhu K, Devesa S, Wu H, Zahm S, Jatoi I, Anderson WF, Peoples GE, Maxwell GL, Granger E, Potter JF, McGlynn KA.  Cancer incidence in the U.S. military population: comparison with rates from the SEER program.  Cancer Epidemiology Biomarkers and Prevention 2009; 18(6): 1740-1745.

      Jatoi I, Anderson WF.  Breast cancer overdiagnosis with screening mammography. Archives of Internal Medicine 2009; 169(10): 999-1000.

      Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC.  Early Breast    Cancer.  Lancet 2009; 373(9673): 1463-1479.

      Andriole GL, Crawford ED, Grubb RL, et al.  PLCO Project Team.  Mortality results from a randomized prostate-cancer screening trial.  N Engl J Med 2009; 360(13): 1310-1319.  Epub 2009 Mar 18

      Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, Wollins DS, Garber JE, Brown P, Kramer BS.  American Society of Clinical Oncology Policy Statement: The Role of the Oncology Professional in Cancer Prevention and Risk Assessment.  (Epub ahead of print on 2008 Dec 15) Journal of Clinical Oncology 2009; 27(6):986-93. 

      Jatoi I, Cummings KM, Cazap E.  Global Tobacco Problem Getting Worse, Not Better.  Journal of Oncology Practice 2009; 5(1): 21-23.

      Jatoi I, Anderson WF, Rosenberg PS.  Qualitative Age-Interactions in Breast Cancer: A Tale of Two Diseases?  American Journal of Clinical Oncology 2008; 31(5): 504-506.

      Jatoi I.  Preface.   Hereditary Cancer Syndromes.  Surg Clin North America 2008; 88(4): xiii. 

      Jatoi I, Anderson WF.  Management of women who have a genetic Predisposition for Breast Cancer.   Surg Clin North America 2008; 88(4): 845-861.

      Oseni T, Jatoi I.  Overview of the role of prophylactic surgery in the management of individuals with a hereditary cancer predisposition.  Surg Clin North America 2008; 88(4): 739-58.

      Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Gooodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O’Regan RM, Garcia-Closas M, Perou CM, Jatoi I, Cartun RW, Sherman ME.  Human epidermal growth factor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveilance, Epidemiology, and End Results (SEER) program.  (Epub ahead of print on 2008 Feb 7).  Breast Cancer Res Treat 2009; 113(1): 189-196.

      Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID, Jatoi I.  Racial disparities in breast cancer outcome: insights into host-tumor interactions.  Cancer 2007; 110(9): 1880-1888.

      Shah M, Zhu K, Wu H, Jatoi I, Palmer R, Shriver C.  Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women.  J Women’s Health 2007; 16(4): 526-534.

      Jatoi I, Chen BE, Anderson WF, Rosenberg PS.  Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.  Journal of Clinical Oncology 2007; 25(13): 1683-1690.

      Sarker M, Jatoi I, Becher I.  Racial differences in breast cancer survival in women under age 60.  Breast Cancer Research and Treatment 2007; 106(1): 135-141.

      Wu H, Zhu K, Jatoi I, Shah M, Shriver CD, Potter J.  Factors associated with the incompliance mammogram screening with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.  Breast Cancer Research and Treatment 2007; 101(3): 317-24. 

      Jatoi I.  Clinical Trials in Surgical Oncology – Introduction.   World Journal of Surgery 2006; 30(7): 1137

      Jatoi I, Proschan MA.   Application of Clinical Trial Results to Management of the Individual Cancer Patient.   World Journal of Surgery 2006; 30(7): 1184-1189

      Jatoi I, Zhu K, Shah M, Lawrence W.  Psychological distress in U.S. women who have experienced false-positive mammograms.  Breast Cancer Research and Treatment 2006; 100(2): 191-200.

      Anderson WF, Jatoi I, Devesa SS.  Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002).  Breast Cancer Research and Treatment 2006; 99(3): 333-340.

      Anderson WF, Chen BE, Jatoi I, Rosenberg PS.  Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.  Breast Cancer Research and Treatment 2006; 100(1): 121-126.

      Nnewman LA, Griffith KA, Jatoi I, Simon M, Crowe JP, Colditz GA.  Meta-analysis of survival in African American and White American Breast Cancer Patients: Ethnicity versus Socioeconomic Status.  Journal of Clinical Oncology 2006; 24(9): 1342-1349.

      Zhu K, Wu H, Jatoi I, Potter J, Shriver CD.  Body mass index and use of mammography screening in the United States.   Preventive Medicine 2006; 42(5): 381-385.

      Jatoi I.  MRI in breast cancer management: potential for benefit and harm. International Journal of Fertility and Womens’ Medicine 2005; 50(6): 281-284.

      Jatoi I, Anderson WF, Rao S, Devesa SS.  Breast cancer trends among black and white women in the United States.   Journal of Clinical Oncology 2005; 23(31): 7836-7841.

      Jatoi I, Anderson WF.  Cancer Screening.   Current Problems in Surgery 2005; 42(9): 620-682.

      Jatoi I, Anderson WF.  In Brief.  Cancer Screening.  Current Problems in Surgery 2005; 42(9): 616-618.

      King B, Jatoi I.  Mobile Army Surgical Hospitals: a military and surgical  legacy. Journal of the National Medical Association 2005; 97(5): 648-656.

      Jatoi I, Proschan MA.  Breast conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of the randomized trials.   American Journal of Clinical Oncology  2005; 28(3): 289-294.

      Cho J, Jatoi I, Alarcon A, Morton T, King B, Hermann J.  Operation Iraqi Freedom: Surgical experience of the 212th MASH.   Military Medicine 2005; 170(4): 268-272.

      Anderson WF, Jatoi I, Devesa SS.  Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program, suggesting a possible link between etiology and outcome.  Breast Cancer Research and Treatment 2005; 90(2): 127-137.

      Jatoi I, TsimelzonA, Weiss H, Clark GM, Hilsenbeck S.  Hazard rates of recurrence following diagnosis of primary breast cancer.   Breast Cancer Research and Treatment 2005; 89(2): 173-178.

      Jatoi I.  Current status of sentinel lymph node biopsy in early breast cancer.    International Journal of Fertility and Women’s Medicine 2004; 49(5): 215-221.

      Jatoi I, Soballe PW, Anderson WF.  Delayed benefit of mammography screening in premenopausal women.  Journal of Clinical Oncology 2004; 22(23): 4808.

      Jatoi I.  Internal mammary sentinel nodes in primary breast cancer.  Current Medical Research and Opinion 2003; 19(6): 567-569. 

      Jatoi I, Becher H, Leake CR.  Widening Disparity in Survival between White and African-American Patients with Breast Carcinoma Treated in the U.S. Department of Defense Healthcare System.  Cancer 2003; 98(5): 894-899.

      Jatoi I.  Screening Clinical Breast Examination.  Surgical Clinics of North America, 2003; 83(4): 789-801.

      Jatoi I, Miller AB.  Why is breast cancer mortality declining?  Lancet Oncology 2003; 4(4): 251-4.

      Kelemen JJ, Poulton T, Swartz MT, Jatoi I.  Surgical treatment of early stage breast cancer in the Department of Defense Health Care System.   Journal of the American College of Surgeons 2001; 192: 293-297.

      Canby-Hagino ED, Morey AF, Jatoi I, Perahia B, Bishoff JT.  Fibrin sealant treatment of splenic injury during open and laparoscopic left nephrectomy.  Journal of Urology 2000; 164(6): 2004-5.

      Kim BS, Sbar AD, Jatoi I.  Intraabdominal Cystic Lymphangioma.  Surgery 2000; 128(5): 834-5.

      Mc Clain JM, Weiss WB, Jatoi I.  Small bowel resection for carcinoid tumor.  Journal of the American College of Surgeons 2000; 191(3): 331.

      Jatoi I.  Management of the axilla in primary breast cancer. Surgical Clinics of North America 1999; 79(5):1061-1073.

      Jatoi I.  The natural history of breast cancer. Surgical Clinics of North America 1999; 79(5):949-960.

      Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. Journal of Clinical Oncology 1999; 17(8):2334-2340.

      Jatoi I.  Breast cancer screening. American Journal of Surgery 1999; 177:518-524.

      Jatoi I.  Timing of surgery for primary breast cancer with regard to the mentrual phase and prognosis.  Breast Cancer Research and Treatment 1998; 52:217-225.

      Jatoi I.  Response to: “The benefits of mammography are not limited to women of ages older than 50 years”.  Cancer 1998; 83(9):2045-2046

      Wilkens TH, Burke BJ, Cancelada DA, Jatoi I.  Evaluation of palpable breast masses with color doppler and gray scale imaging. Journal of Ultrasound Medicine 1998;17:109-115.

      Jatoi I.  Breast cancer: a systemic or local disease?  American Journal of Clinical Oncology 1997; 20(5):536-539.

      Jatoi I.   Neoadjuvant progesterone therapy for primary breast cancer: rationale for a clinical trial.  Clinical Therapeutics 1997;19(1):56-61

      Jatoi I, Trott P.  False positive reporting in breast fine needle aspiration cytology:  incidence and causes.  The Breast 1996; 5: 270-273.

      Jatoi I.  Detection and treatment of ductal carcinoma in situ.  JAMA 1996;276(11):870.

      Jatoi I.  Mammographic screenings for women under 50.  American Journal of Surgery 1996;172:304

      Jatoi I, Clark CM, deMoor C, Hilsenbeck SG, Osborne CK.  Axillary lymph node metastasis in primary breast cancer: An indicator of tumor chronology or biology? Proceedings of the American Society of Clinical Oncology 1995; 14:100

      Jatoi I, Baum M.  Mammographically detected ductal carcinoma in situ:  Are we overdiagnosing breast cancer?  Surgery 1995; 118:118-20.

      Jatoi I.  Mammographic screening for women 40 to 49 years of age.  Annals of Internal Medicine 1995; 123:634.

      Jatoi I, Mansi J, Bliss J, Baum M, Coombes C.  Influence of menopause on bone marrow micrometastasis in early breast cancer.  XVI International Cancer Congress, New Delhi, 1994, XVI International Cancer Congress 1994  Book-1, PSBR5-06, 160

      Jatoi I, Gore ME.  Sex, pregnancy, hormones, and melanoma.  British Medical Journal 1993; 307:2-3.

      Jatoi I, Baum M.  American and European recommendations for screening mammography in younger women:  a cultural divide? British Medical Journal 1993; 307:1481-1483.

      Benson JR, Lau Y, Jatoi I, Baum M.  Early breast cancer:  diagnosis and management. Update 15, September 1993; 337-345.

      Jatoi I, Lawhon CL, Mansbridge JN, Richards V.  Immunohistochemical localization of transforming growth factor-B1 in epithelializing human keratinocyte inclusion cysts grown in athymic mice.  Surgical Research Communications 1991; 10:117-125.

      Jatoi I, Slavin RG, Alvey YG.  Immune response in experimentally induced uremia.  VII uremic thymocytes amplify the response of control lymph node cells to alloantigens.  Clinical Immunology and Immunopathology 1984;30(1):80-90.

      Kim YS, Yoon YJ, Jatoi I, Kim Y.  Fetal macrosomia in diabetic multiparous animals.  Diabetologia 1981;20(3):213-216.

      Kim YS, Yoon YJ, Jatoi I, Kim Y.  Fetal macrosomia in experimental maternal diabetes.  American Journal of Obstetrics and Gynecology 1981;139(1):27-32.

      Kim YS, Jatoi I, Kim Y.  Neonatal macrosomia in maternal diabetes. Diabetologia 1980;18(5):407-411.

      Kim YS, Jatoi I, Kim Y.  Regulation of DNA synthesis and DNA polymerase in rat pancreas.  II age-dependant changes in glucocorticoid control.  Experimental and Molecular Pathology 1979; 30(2):264-270.

      Kim YS, Jatoi I, Kim Y.  Regulation of DNA synthesis and DNA polymerase in rat pancreas.  I glucocorticoid control in young animals.  Experimental and Molecular Pathology 1979; 30(2):255-263.

      Books:

      Jatoi I, Benson JR, Sbitany H.  Atlas of Breast Surgery, 2nd Edition.  Springer, New York, 2020 (scheduled for publication).

      Jatoi I. Rody A. Management of Breast Diseases (2nd Edition), New York, 2016

      Holloway T, Jatoi I.  Personalized Management of Breast Cancer (e-book). Future Medicine LTD, London, 2014

      Jatoi I, Kaufmann M.  Management of Breast Diseases.  Springer, New York, 2010

      Benson J, Jatoi I.  Management options in Breast cancer: International Guidelines for Best Practice and Clinical Judgement.  Informa Healthcare, London, 2009.

      Jatoi I, Kaufmann M, Petit JY.  Atlas of Breast Surgery.  Springer, New York, 2006.

      Jatoi I (Editor).  Manual of Breast Diseases.  Lippincott Williams and Wilkins, Philadelphia, 2002

      Book Review:

      Annals of Surgery 2002; 236(5): 693

      Jatoi I (Editor).  Breast Cancer Screening.  Landes Bioscience/Chapman and Hall, NY, 1997.  (Marketed by Springer-Verlag outside of North America.)

      Book Reviews:

      New England Journal of Medicine 1997;337(21);1564-1565

      Journal of the National Cancer Institute 1998;90(21):1669.

      Book Chapters:

      Jatoi I.   Breast Care Problems (Sections 3-5 to 3-9).  In: Special Operations Forces Medical Handbook, 2nd Edition. U.S. Government Printing Office, Washington, DC, 2008        

      Oseni TS, Jatoi I.  Health care disparities.  In Feuerstein M, editor.  Handbook of cancer survivorship.  Springer, New York, 2007.

      Jatoi I, Baum M.   Mammographic Screening in Women under Age 50.  In

      Querci della Rovere G, Warren R, Benson JR, eds.  Early Breast Cancer: From Screening to Multidisciplinary Management, 2nd Edition.  Taylor and Francis, London, 2006.

      Jatoi I.  Surgery for Primary Invasive Breast Cancer.   In Jatoi I, ed.  Manual of Breast Diseases.  Lippincott Williams and Wilkins, Philadelphia, 2002

      Jatoi I.  Principles of Breast Cancer Screening.  In Jatoi I, ed.  Manual of Breast Diseases.  Lippincott Williams and Wilkins, Philadelphia, 2002

      Jatoi I. Evidence of Benefit of Screening in Other Cancers.  In: Thompson IM, Resnick MI, Klein EA, ed.  Prostate Cancer Screening.  Humana Press, Totowa, New Jersey, 2001

      Jatoi I, Baum M.  Mammographic Screening in Women Under age 50:  A Critical Appraisal.  In: Morgan MWE, Warren R, Querci Della Rovere G, eds.  Early Breast Cancer.  Harwood Academic Publishers, London, 1998.

      Jatoi I.  The Case Against Mammographic Screening for Women in their Forties. In: Jatoi I, ed.  Breast Cancer Screening.  Landes Bioscience/Chapman Hall, New York, 1997.

      Guest Editor:

      Jatoi I (Guest Editor) Surgical Clinics of North America.  Hereditary Cancer   Syndromes.  Elsevier, Vol 88(4), August, 2008.

      Jatoi I, Singletary SE (Guest Editors) Surgical Clinics of North America.  Breast Cancer: New Concepts in Management.   WB Saunders Company, Volume 83(4), August, 2003.

      Jatoi I.  (Guest Editor)  Surgical Clinics of North America.  Breast Cancer Management.  WB Saunders Company, Vol. 79(5), October, 1999 

       

  • Clinical

    Board Certifications

    • 1993 - Fellow of the American College of Surgeons (FACS)
    • 1991 - General Surgery-The American Board of Surgery